Chemical Compound Review:
CHEMBL82327 (2R)-2-[[4-[(3- fluorophenyl)methoxy]phenyl...
Synonyms:
AC1NUPG0, SureCN194169, CHEBI:235095, DNC013330, M6252, ...
- Improvement of motor function in early Parkinson disease by safinamide. Stocchi, F., Arnold, G., Onofrj, M., Kwiecinski, H., Szczudlik, A., Thomas, A., Bonuccelli, U., Van Dijk, A., Cattaneo, C., Sala, P., Fariello, R.G. Neurology (2004)
- Safinamide: from molecular targets to a new anti-Parkinson drug. Caccia, C., Maj, R., Calabresi, M., Maestroni, S., Faravelli, L., Curatolo, L., Salvati, P., Fariello, R.G. Neurology (2006)
- Pressor response to intravenous tyramine in healthy subjects after safinamide, a novel neuroprotectant with selective, reversible monoamine oxidase B inhibition. Cattaneo, C., Caccia, C., Marzo, A., Maj, R., Fariello, R.G. Clinical neuropharmacology. (2003)
- Safinamide. Fariello, R.G. Neurotherapeutics (2007)
- Symptom relief in Parkinson disease by safinamide: Biochemical and clinical evidence of efficacy beyond MAO-B inhibition. Stocchi, F., Vacca, L., Grassini, P., De Pandis, M.F., Battaglia, G., Cattaneo, C., Fariello, R.G. Neurology (2006)
- Bioassay of safinamide in biological fluids of humans and various animal species. Dal Bo, L., Mazzucchelli, P., Fibbioli, M., Marzo, A. Arzneimittel-Forschung (2006)
- Pharmacokinetics and pharmacodynamics of safinamide, a neuroprotectant with antiparkinsonian and anticonvulsant activity. Marzo, A., Dal Bo, L., Monti, N.C., Crivelli, F., Ismaili, S., Caccia, C., Cattaneo, C., Fariello, R.G. Pharmacol. Res. (2004)